Pharmaceutical companies in talks with NICE about access to Alzheimer’s drugs Drug manufacturers Lilly and Eisai are in discussion with the National Institute for Health and Care Excellence to appeal the regulator’s rejection of the use of donanemab and lecanemab on the NHS for the third time in June 2025.…
MHRA report finds insufficient data on bladder anticholinergics dementia risk The regulator also said limitations observed in several studies revealed that a “small increased risk” of dementia related to the use of bladder anticholinergic medicines cannot be ruled out entirely.…
Patient death prompts concerns about clozapine and smoking cessation awareness A patient died in October 2025 from fatal clozapine toxicity after he suddenly stopped smoking.…
MenB vaccine supply ‘bolstered’ for NHS England pharmacy campaign NHS England has said that under its meningitis B vaccination service, around 135,000 bookings were made for the jab during the first week of the campaign’s launch.…
Study develops first framework to estimate country-level antibiotic need The Independent Panel for Evidence for Action on AMR will evaluate targets, policies and regulations to help countries improve their antibiotic use and access.…
Health news round-up: vaccination, testosterone and neighbourhood health The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
Stopping antipsychotics in patients with dementia reduces risk of fracture and delirium The study’s lead author said the “findings provide reassurance” that stopping long-term antipsychotic treatment when no longer needed prevents harms.…
Electronic prescription service: the battle for nominations Allegations that electronic prescription service nominations are being switched without patients’ consent have prompted concerns over safety. The Pharmaceutical Journal investigates the potential impact.…
‘Stark lack of government response’ on valproate redress, patient safety commissioner says In her annual report for 2025/2026, Henrietta Hughes said the government was “yet to announce a redress scheme or a timeline for providing a substantive response to the recommendations” made in her previous report on patients harmed by sodium valproate.…
Health news round-up: ‘landmark’ long COVID trial results and are contraceptives linked to brain tumours? The Pharmaceutical Journal’s weekly summary of the important developments in pharmacy and health news you may have missed.…
